Christopher M. Cherry, Ph.D.

Christopher M. Cherry, Ph.D.


Alexandria, VA

Chris focuses his practice on intellectual property law, in particular, inter partes proceedings before the USPTO (interferences, inter partes review, post-grant review, and reexaminations), representing both petitioners and patent owners. Chris also has vast experience in patent prosecution, freedom-to-operate analyses, due diligence, and non-infringement and invalidity opinions. He has experience working with larger companies, start-ups, universities, and with recruiting and managing scientific experts.

He is trained in biomedical research including molecular biology, cell biology, biochemistry, stem cell biology, cloning, protein purification, antibody production, immunolocalization, confocal microscopy, western blotting, ELISA, genetics, and epigenetics. Chris has worked on IP matters covering a wide range of technologies, including biofuels, nutraceuticals, antibodies, pharmaceuticals, small molecules, molecular and cell biology, diagnostics, genetic engineering, gene editing, and personalized medicine.

Chris’ graduate research focused on the molecular mechanisms that regulate stem cell maintenance within their endogenous microenvironment, or niche. In particular, the role of cell signaling pathways and epigenetic regulators, including ATP-dependent chromatin remodeling factors, in maintaining stem cells within Drosophila stem cell niches. His research in the lab resulted in two peer-reviewed publications, including a first-author publication in the journal Cell Stem Cell

Prior to joining Buchanan, Chris was an associate at an Intellectual Property law firm based in Washington, D.C., where he worked on USPTO inter partes matters, formulated and prepared non-infringement and invalidity opinions in the pharmaceutical arena, and drafted and prosecuted patent applications in the fields of molecular biology, gene therapy, pharmaceuticals, biofuels, and nutraceuticals.


Todd R. Walters, Erin M. Dunston, Jonathan R. Bowser, Roger H. Lee, Kyle K. Tsui, Mythili Markowski, Christopher M. Cherry, David W. Leibovitch, and Shantanu C. Pathak (2017), “The Evolution of Patent Office Litigation Practice Under the AIA,” Landslide 9(3): 40-46.

Li Y., Ma Q., Cherry CM, Matunis EL, “Steroid signaling promotes stem cell maintenance in the Drosophila testis,” Dev. Biol. 394(1):129-41 (2014)

Cherry CM and Matunis EL, “Epigenetic regulation of stem cell maintenance in the Drosophila testis via the nucleosome remodeling factor NURF,” Cell Stem Cell 6(6):557-67 (2010)